ASTH vs MEG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

ASTH

60.0
AI Score
VS
MEG Wins

MEG

63.0
AI Score

Investment Advisor Scores

ASTH

Aug 02, 2026
60score
Recommendation
BUY

MEG

Aug 02, 2026
63score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ASTH MEG Winner
Forward P/E 23.0415 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 55.6% 2.2% ASTH
Earnings Growth 110.1% 0.0% ASTH
Tradestie Score 60.0/100 63.0/100 MEG
Profit Margin 0.9% -0.1% ASTH
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY BUY Tie

Relative Price Performance (Last 90 Days)

ASTH 1M: -28.6% · 3M: +4.2% MEG 1M: -1.0% · 3M: -0.6%

Current Technical Phase

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 28

RSI (14): 28.1 · Price: $35.56

MEG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.2 · Price: $22.14

Fundamentals Snapshot

Metric ASTH MEG
Market Cap
Forward P/E 10.4 13.6
Trailing P/E 60.1
Revenue (TTM)
Revenue Growth 0.6% 0.0%
Gross Margin 0.1% 0.4%
Operating Margin 0.0% 0.0%
EPS 0.61 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MEG is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.